WARNING: This product is for research use only, not for human or veterinary use.
MedKoo CAT#: 465228
CAS#: unknown
Description: MB002 is CK2 ligand.
MedKoo Cat#: 465228
Name: MB002
CAS#: unknown
Chemical Formula: C9H7Br4N3O
Exact Mass: 488.7323
Molecular Weight: 492.791
Elemental Analysis: C, 21.94; H, 1.43; Br, 64.86; N, 8.53; O, 3.25
This product is not in stock, which may be available by custom synthesis.
For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge).
Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.
Synonym: MB002; MB 002; MB-002;
IUPAC/Chemical Name: 3-(perbromo-1H-benzo[d][1,2,3]triazol-1-yl)propan-1-ol
InChi Key: VXLNELSTYPRMEW-UHFFFAOYSA-N
InChi Code: InChI=1S/C9H7Br4N3O/c10-4-5(11)7(13)9-8(6(4)12)14-15-16(9)2-1-3-17/h17H,1-3H2
SMILES Code: BrC1=C2C(N(CCCO)N=N2)=C(Br)C(Br)=C1Br
Appearance: Solid powder
Purity: >98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Solubility: To be determined
Shelf Life: >2 years if stored properly
Drug Formulation: To be determined
Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).
HS Tariff Code: 2934.99.9001
The following data is based on the product molecular weight 492.791 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
1: Kaminska B, Ellert-Miklaszewska A, Oberbek A, Wisniewski P, Kaza B, Makowska M, Bretner M, Kazimierczuk Z. Efficacy and mechanism of anti-tumor action of new potential CK2 inhibitors toward glioblastoma cells. Int J Oncol. 2009 Nov;35(5):1091-100. doi: 10.3892/ijo_00000424. PMID: 19787263.
